PDGFRB is a receptor tyrosine kinase (RTK) known to be expressed by stromal fibroblasts in several cancers and high stromal PDGFRB expression is associated with poor survival, e.g. in breast and prostate cancers [30, 31, 32, 33, 34]. Here, PDGFRB is linked to prostate carcinoma.